维普中文期刊产品整合服务
110篇 您的检索式:作者名="Marso SP"
    题名 作者 年代 出处 被引量
1Semaglutide降低2型糖尿病患者的心脑血管事件风险显示文摘心血管疾病是2型糖尿病患者发生并发症和死亡的主要原因。最近的一些临床试验报告,一种钠-葡萄糖协同转运蛋白-2抑制剂(依帕列净)和一种胰高血糖素样肽-1(GLP-1)类似物(利拉鲁肽),能够改善心血管高风险的2型糖尿病患者的心血管结局。Semaglutide是GLP-1的一种类似物,半衰期长达约1周,可以一周一次皮下注射,但是尚不清楚其对2型糖尿病患者的心血管效应;由于Semaglutide目前处于开发阶段,尚未被批准用于治疗2型糖尿病。Marso SP Bain SC Consoli A 王建中 2016中华肾病研究电子杂志2016,5,5:141
2Increase in intedeukin-6 following arterial injury is related to insulin resistance, the -174G→polymorphism and complex plaque morphology 显示文摘Marso SP House JA Hopkins PJ 2006Int J Immunogenet2006,33,:1
3Angiotensin - converting en- zyme inhibitors angiotensin receptor blockers for prevention of type 2 dia- betes: a meta- analysis of randomized clinical trials 显示文摘Abuissa H Jones PG Marso SP 2005J Am Coil Cardiol2005,46,5:1
4Cardiovascular safety ofliraglutide assessed in a patient-level pooled analysis of phase 2:3 limglutide clinical development studies显示文摘Marso SP Lindsey JB Stolker JM 2011Diab Vase Dis Res2011,8,3:1
5Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries:A 20-year experience显示文摘Suero JA Marso SP Jones PG 2001J Am Coll Cardiol2001,38,:1
6Peripheral arterial disease in patients with diabetes显示文摘Marso SP Hiatt WR 2006J Am Coli Cardiol2006,47,5:1
7Chronic total occlusion angioplasty in the United States显示文摘Grantham JA Marso SP Spertus J 2009J Am Coll Cardiol lntv2009,2,6:1
8Diabetes mellitus is associated with a shift in the temporal risk profile of inhespital death after peroutaneous coronary intervention:An analysis of 25223 patients over 20 years显示文摘Marso SP Giorgi LV Johnson WL 2003Am Heart J2003,145,:1
9Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus显示文摘 Marso SP Zhou Z 2001Circulation2001,104,7:1
10Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel显示文摘Safley DM House JA Marso SP 2008JACC Cardiovasc Interv2008,1,3:1
11Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience 显示文摘Suero JA Marso SP Jones PG 2001J Am Coil Cardiol2001,38,40:1
12Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus:results of the EPISTENT(evaluation of platelet Ⅱb/Ⅲa inhibitor for stenting trial) diabetic substudy显示文摘Marso SP Lincoff AM Ellis SG 1999Circulation1999,100,:1
13Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus显示文摘Bhatt DL Marso SP Hirsch AT 2002Am J Cardiol2002,90,6:1
14Muitivessel percutaneous coro- nary intervention in patients with muhivessel disease and acute myo- cardial infarction显示文摘Corpus RA House JA Marso SP 2005Am Heart J2005,14,1:1
15Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions:variability by target vessel显示文摘Safley DM House JA Marso SP 2008JACC Cardiovasc Interv2008,1,3:1
16Abciximab reduces mortality in diabetics following percutaneous coronary intervention显示文摘Bhatt DL Marso SP Lincoff AM 2000JACC2000,35,:1
17Amplified benefit of clopidogrel versus aspirin inpatiens with diabetes mellitus显示文摘Bhatt DL Marso SP Hirsch AT 2002Am J Cardiol2002,90,6:1
18Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries:a 20 year experience显示文摘Suero JA Marso SP Jones PG 2001J Am Coll Cardiol2001,38,2:1
19Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries:a 20-year experience显示文摘Suero JA Marso SP Jones PG 2001J Am Coll Cardiol2001,38,:1
20Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries显示文摘Marso SP Mehta SK Frutkin A 2008Diabetes Care2008,31,5:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费